NuScale Power Stock Falls 70% in 6 Months. Here's Why the Nuclear Energy Company Faces Headwinds.

NuScale Power could benefit from rising interest in nuclear reactors for space, with the U.S. targeting orbit deployment by 2028 and a lunar reactor by 2030. The company has an edge from having the only SMR design approved by the NRC and over 700 granted or pending patents, but it remains unprofitable, has not built a commercial reactor, and its stock is still down more than 70% over the past six months. The article frames the opportunity as long-dated and speculative rather than an immediate fundamental inflection.

Analysis

The market is assigning NuScale an option value on a very long-dated procurement story, but the near-term catalyst is more about signaling than revenue. A space-reactor program, if it progresses, improves NuScale’s credibility with regulators and primes a customer-pipeline narrative that can compress financing risk for peers in the SMR stack. The second-order winner is likely the broader nuclear supply chain and engineering firms with government-contracting leverage, while pure developers remain exposed to milestone slippage and capital dilution.

The key issue is timing mismatch: policy enthusiasm can re-rate the stock in days, but contract conversion and first deployment are measured in years. That creates a fragile setup where any delay in government budgets, launch schedules, or safety qualification can unwind the move quickly. Because NuScale is pre-commercial, the equity behaves more like a binary development asset than a utility-style compounder, so valuation sensitivity to newsflow is unusually high.

Consensus appears to be overestimating how much a space program changes the core economics of SMRs. The real bottleneck is not engineering ambition; it is whether recurring terrestrial demand emerges fast enough to justify manufacturing scale before the funding window closes. If the market starts treating this as a moonshot rather than a pipeline, the rally can extend, but fundamental downside remains steep if the next 1-2 quarters fail to produce a contract or a credible commercialization milestone.

Key Decisions for Investors

• Trade SMR as a tactical momentum long, not a core holding: initiate only on pullbacks and use a 4-8 week horizon into any NASA/DoD policy headlines; take profits aggressively on 20-30% spikes because the move is narrative-driven.
• For cleaner exposure, prefer a basket trade: long SMR vs. short an underappreciated delayed-commercialization peer in the broader nuclear development complex; the relative trade captures policy upside while hedging sector beta.
• Use call spreads rather than stock for SMR: 1-3 month upside structures limit downside if contract timing slips, with best risk/reward around catalyst windows and defined loss.
• Avoid chasing the move if the stock gaps higher on headlines; wait for confirmation via volume plus an actual procurement milestone, because headline-only rallies in pre-revenue infrastructure names typically retrace 15-25% within weeks.
• If seeking longer-duration exposure, pair a modest SMR position with a short in a capital-intensive industrial/energy contractor most vulnerable to delayed nuclear capex; the spread reduces thesis risk if broad risk sentiment weakens.